Baseline characteristics for INFRONT 3: A Phase 3 double blind, placebo[...]
Notification Letter and Reply Form to Non registered Shareholders[...]
10/08/2021 | Press release | Distributed by Public on 10/08/2021 09:30
Please select the service you want to use:
Smartlinks | Pershing Square Holdings Ltd. | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Public Companies | Investment Companies | London Stock Exchange (LSE) | Börse Frankfurt | Börse Stuttgart | OTC Markets | Turquoise | Euronext Amsterdam | Cboe BXE Europe | Cboe CXE Europe | Cboe Off Exchange | Börse Berlin Equiduct Trading | Aquis Exchange | SIGMA X MTF | Euronext Block MTF
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact